Jiang, Jie
Sun, Qi
Xie, Jingjun
Sun, Jianwei
Funding for this research was provided by:
Huzhou Science and Technology Plan Public Welfare Application Research Project (No. 2022GZB05)
Article History
Received: 22 March 2025
Accepted: 4 June 2025
First Online: 1 July 2025
Declarations
:
: The study protocol received approval from the Medical Research and Clinical Trial Committee of the First People’s Hospital of Huzhou, with the approval document number HZYY-LL–SG-018-01. Written informed consent was obtained from all participants. all methods were carried out in accordance with relevant guidelines and regulations—Declaration of Helsinki. Written informed consent was obtained from all participants. A statement was written to inform the participants that their responses will be treated confidentially. They were also informed that participation was voluntary.
: Not applicable.
: The authors declare no competing interests.